Record overview
Status and phase
Status: TERMINATED
Phase: PHASE2
Sponsor: Incyte Corporation
Condition: Urothelial Carcinoma
NCT04586244
An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Registry Stop Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: strict_eligibility_signal
Stopped reason
Context when available
Business Decision. No safety concerns contributed to this decision.